MTOR and breast carcinoma: Taken together, our results identify THBS1- or TNC-activated integrin β1/mTOR signaling respectively as an important survival pathway in chemotherapy-induced growth inhibition in breast cancer cells and suggest that activation of this pathway may contribute to the development of chemotherapy resistance.